NCT03162133
- Conditions
- Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Guangdong General Hospital Guangzhou, Guangdong, China
Clinical trial condition
Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy
Explore clinical trials studying Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies